Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-200331
Filing Date
2021-06-25
Accepted
2021-06-25 16:03:24
Documents
4
Effectiveness Date
2021-06-25

Document Format Files

Seq Description Document Type Size
1 S-8 d193096ds8.htm S-8 69795
2 EX-5.1 d193096dex51.htm EX-5.1 4833
3 EX-23.1 d193096dex231.htm EX-23.1 1523
4 EX-99.2 d193096dex992.htm EX-99.2 319990
  Complete submission text file 0001193125-21-200331.txt   397169
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257406 | Film No.: 211047675
SIC: 2836 Biological Products, (No Diagnostic Substances)